Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2025 10:36 ET | Source: PRISM MarketView

PRISM MarketView Spotlights Opus Genetics in New Q&A with CEO George Magrath

PRISM MarketView Spotlights Opus Genetics in New Q&A with CEO George Magrath
April 29, 2022 11:36 ET | Source: Ocugen

Ocugen, Inc. to Present Preclinical Results at The Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting

MALVERN, Pa., April 29, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing and commercializing novel gene therapies, biologicals and...
December 11, 2019 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR Announces First Patient Dosed in Phase 1/2 Aurora Trial of QR-1123 for Autosomal Dominant Retinitis Pigmentosa

LEIDEN, Netherlands and CAMBRIDGE, Mass., Dec. 11, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA...
November 21, 2019 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR Receives Orphan Drug Designation from FDA for QR-1123 for Autosomal Dominant Retinitis Pigmentosa

LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of...
October 10, 2019 06:00 ET | Source: ProQR Therapeutics N.V.

ProQR Announces Positive Top-Line Results from the Phase 1/2 Study of Sepofarsen in LCA10 Patients

Reported rapid, significant and durable improvements in vision at twelve monthsConcordant improvement in key secondary outcome measuresThe target registration dose of sepofarsen was well-tolerated...
October 02, 2019 07:00 ET | Source: Foundation Fighting Blindness

Blueprint Genetics, InformedDNA and the Foundation Fighting Blindness launch an open access program for patients with inherited retinal disease in the United States

COLUMBIA, Maryland, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Blueprint Genetics, InformedDNA and the Foundation Fighting Blindness have announced that beginning in October 2019, a new open-access program...
June 03, 2019 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR to Present at the JMP Securities Life Sciences Conference

LEIDEN, the Netherlands and CAMBRIDGE, Mass., June 03, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative...
January 29, 2019 08:30 ET | Source: ProQR Therapeutics N.V.

ProQR Announces “ProQR Vision 2023” Strategy at its Annual R&D Day

LEIDEN, the Netherlands & CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative...